LIVZON PHARMA

1513
24.8200.64% ( -0.160 )
Delay Trading: Nov 17, 10:04:21

Financials

Q3 FY2026 Earnings

Financial report interval: 2026.06.30 - 2026.09.30

Overview: LIVZON PHARMA(01513) the Revenue is 2.714 B (-12.7%), Miss estimate;the EBIT is 597.14 M (-19.35%), Miss estimate;the EPS is 0.468 (--%), Miss estimate.

Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
2.71B12.70%
3.00B3.50%
-0.29B9.20%
EBITMiss expectations
0.60B19.35%
0.68B8.38%
-0.08B10.97%
EPSMiss expectations
0.468--
0.5967--
-0.1287--%

Upcoming earnings report - FY2026 Annual Earning Release

Available dateMar 26, 2027
Estimate Revenue11.49 B
Estimate EBIT--
Estimate EPS2.075

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly